Navigation Links
Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update
Date:10/12/2007

LAVAL, QC, Oct. 12 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. (Neptune) (NASDAQ.NEPT - TSX.V.NTB), "Neptune" today announced its results for the first quarter ended August 31st, 2007.

Neptune's Highlights:

- First Quarter ended August 31, 2007:

- Sales increased by 34% to $2,085,000 compared to $1,552,000, for

the first quarter of the fiscal year ended May 31st, 2007.

- EBITDA increased by 10% to $332,000 compared to $303,000 for the

first quarter of the fiscal year ended May 31st, 2007.

- Excluding non-monetary stock-based compensation expenses for both

years, Neptune would have realized earnings of $22,000 instead of

a loss of $1,051,000 for the first quarter of the fiscal year

ended May 31st, 2008 compared to earnings of $48,000 instead of a

loss of $286,000 for the same period of last year.

"Neptune continues its worldwide commercialization efforts which translates into great sales progress which generates sufficient cash flow to finance our normal business operations growth", stated Mr. Andre Godin, Vice President, Administration and Finance.

Business Update:

Neptune continues to strongly support its strategic development plan to form partnerships/strategic alliances with worldwide leaders in the nutraceutical and pharmaceutical industries. In accordance with its plan, Neptune has signed agreements with Nestle and Yoplait paving its entrance in the global functional food market. According to its business strategy, negotiations with pharmaceutical companies with the objective of entering into the pharmaceutical market by licensing rights is an ongoing and top priority for Neptune.

Neptune announces a corporate reorganization following recent progress in strategic and business development. Dr. Tina Sampalis has been promoted to Chief Scientific Officer and Thierry Houillon,
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Barriers will not stop convergence of medical technologies
2. Merge Technologies net loss doubles to $10.1M
3. Making deals with evolving technologies in mind
4. Third Wave Technologies to raise $14.9M through private debt
5. Meier joins Broadlook Technologies as COO
6. Platypus Technologies secures $450K SBIR grant
7. Napier joins board of Third Wave Technologies
8. aOva Technologies raises $3 million
9. Consumer, business technologies face same challenges
10. Promega to get early access to WARF technologies under new agreement
11. Linda Weber to run Fiservs Interactive Technologies unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 A ... the NCATS rare-diseases portfolio " in Science ... new financing technique to reduce the risk associated ... and potentially unlock new levels of funding for ... product of a unique collaboration between scientists at ...
(Date:2/27/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY) is to present important ... patients with metastatic renal cancer at the ASCO Genitourinary ... The data will be presented by Dr. Sumanta ... Center in California in his ... Ferritin and IL-8 as two baseline biomarkers that correlate ...
(Date:2/27/2015)...  Steep Hill, the industry leader in cannabis testing ... open a full service medical cannabis quality assurance laboratory ... advanced scientific tools and methodology to the state, for ... currently the only laboratory licensed by the New Mexico ... in order to meet the recently adopted regulatory requirements ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading ... Kate Black as Privacy Officer and Corporate Counsel. ... state privacy laws as well as health care regulations. ... she will be responsible for reviewing, updating and enhancing ... the U.S. and abroad. She joined the company January ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 223andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
... Although the <A , href="http://www.ambion.com/catalog/CatNum.php?1632"> ... were developed for labeling siRNA, they can , ... can be used for this application. See "<A , ... Introduced dsRNA in Cells " for experimintal data using dsRNA , ...
... , May 20, 2002, ... initially considered a bizarre phenomenon limited to petunias and a few ... topics in molecular biology , (<A , ... it has become clear that PTGS occurs in both plants , ...
... border=0 align="left" cellPadding=8 cellSpacing=1>, , ... Assays , Northern Blotting , ... , , ... Yes , Yes , Yes ...
Cached Biology Technology:Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 2Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 3Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 4RNA Interference and Gene Silencing: History and Overview 2RNA Interference and Gene Silencing: History and Overview 3RNA Interference and Gene Silencing: History and Overview 4RNA Interference and Gene Silencing: History and Overview 5RNA Interference and Gene Silencing: History and Overview 6RNA Interference and Gene Silencing: History and Overview 7RNA Interference and Gene Silencing: History and Overview 8RNA Interference and Gene Silencing: History and Overview 9RNA Interference and Gene Silencing: History and Overview 10RNA Interference and Gene Silencing: History and Overview 11RNA Interference and Gene Silencing: History and Overview 12RNA Interference and Gene Silencing: History and Overview 13RNA Interference and Gene Silencing: History and Overview 14RNA Interference and Gene Silencing: History and Overview 15RNA Interference and Gene Silencing: History and Overview 16RNA Interference and Gene Silencing: History and Overview 17RNA Interference and Gene Silencing: History and Overview 18RNA Interference and Gene Silencing: History and Overview 19RNA Interference and Gene Silencing: History and Overview 20RNA Interference and Gene Silencing: History and Overview 21RNA Interference and Gene Silencing: History and Overview 22RNA Interference and Gene Silencing: History and Overview 23RNA Interference and Gene Silencing: History and Overview 24Comparison of Different Methods of mRNA Quantitation 2Comparison of Different Methods of mRNA Quantitation 3
(Date:2/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces it ... Conference on January 29 th at 10:30 a.m. ... of NXT-ID will present and host a live Q&A ... and its full suite of biometric technologies. Investors can ...
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform ... State of Washington,s Department of Licensing, in the ... issuance system for driver,s licenses and identification cards to its ... development will start in January 2015, with enrollment and card ...
(Date:1/22/2015)... Jan. 16, 2015  A man-made form of insulin delivered ... mental capabilities in adults with mild cognitive impairment and ... by researchers at Wake Forest Baptist Medical Center. ... amnesic mild cognitive impairment (MCI) or mild to moderate ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... the last decade, Asian farmers have cleared tens of thousands ... demand for palm oil, an increasingly popular food ingredient. Ancient ... cut down. As a result, the landscape of equatorial Asia ... and having a serious impact on the air as well ...
... UC Santa Barbara have made a significant discovery in understanding ... nature,s way of controlling whether these cells will renew, or ... or any other part of the human body. The study ... Cell . The scientists say the finding bodes ...
... flu interventions must be imposed quickly, if they are ... journal BMC Public Health have shown that ... within the home should reduce infection, but only if ... maintained for a relatively long period. Professor George ...
Cached Biology News:NASA study says climate adds fuel to Asian wildfire emissions 2NASA study says climate adds fuel to Asian wildfire emissions 3NASA study says climate adds fuel to Asian wildfire emissions 4Scientists shed light on inner workings of human embryonic stem cells 2Scientists shed light on inner workings of human embryonic stem cells 3Social separation stops flu spread, but must be started soon 2
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Normal human AB serum, pooled...
Recombinant Human HGF...
Recombinant Mouse MMP-9, CF...
Biology Products: